Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses

European Journal of Immunology

Volumn 46, Issue 10, 2016, Pages 2426-2437

  Vlasova, Anastasia N ^a   Shao, Lulu ^a   Kandasamy, Sukumar ^a   Fischer, David D ^a   Rauf, Abdul ^a   Langel, Stephanie N ^a   Chattha, Kuldeep S ^a   Kumar, Anand ^a   Huang, Huang Chi ^a   Rajashekara, Gireesh ^a   Saif, Linda J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Childhood diarrhea; Dendritic cells; E. coli Nissle 1917; Human rotavirus; L. rhamnosus GG; Natural killer cells; Probiotics

Indexed keywords

ALPHA INTERFERON; CD172 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; LYMPHOCYTE ANTIGEN; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY ASSAY; DIARRHEA; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ESCHERICHIA COLI; GNOTOBIOTICS; HUMAN ROTAVIRUS; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; LACTOBACILLUS RHAMNOSUS; LYMPHOCYTE FUNCTION; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PORCINE MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAVIRUS INFECTION;

EID: 84990818415     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646498     Document Type: Article

References (62)

1. Round, J. L., O'Connell, R. M. and Mazmanian, S. K., Coordination of tolerogenic immune responses by the commensal microbiota. J. Autoimmun. 2010. 34: J220–J225.
2. Round, J. L. and Mazmanian, S. K., The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009. 9: 313–323.
3. Guinane, C. M. and Cotter, P. D., Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap. Adv. Gastroenterol. 2013. 6: 295–308.
4. Bien, J., Palagani, V. and Bozko, P., The intestinal microbiota dysbiosis and Clostridium difficile infection: Is there a relationship with inflammatory bowel disease? Therap. Adv. Gastroenterol. 2013. 6: 53–68.
5. Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J. C., Pot, B. and Grangette, C., A key role of dendritic cells in probiotic functionality. PLoS One 2007. 2: e313.
6. Sugimura, T., Takahashi, H., Jounai, K., Ohshio, K., Kanayama, M., Tazumi, K., Tanihata, Y. et al., Effects of oral intake of plasmacytoid dendritic cells-stimulative lactic acid bacterial strain on pathogenesis of influenza-like illness and immunological response to influenza virus. Br J Nutr 2015. 114: 727–733.
7. Guandalini, S., Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol. 2011. 45: S149–S153.
8. Hemarajata, P. and Versalovic, J., Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap. Adv. Gastroenterol. 2013. 6: 39–51.
9. Saif, L. J., Ward, L. A., Yuan, L., Rosen, B. I. and To, T. L., The gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses. Arch. Virol. Suppl. 1996. 12: 153–161.
10. Tate, J. E., Burton, A. H., Boschi-Pinto, C., Steele, A. D., Duque, J., Parashar, U. D. and Network, W. H.-c. G. R. S., 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012. 12: 136–141.
11. Gray, J., Rotavirus vaccines: safety, efficacy and public health impact. J. Intern. Med. 2011. 270: 206–214.
12. Foye, O. T., Huang, I. F., Chiou, C. C., Walker, W. A. and Shi, H. N., Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. FEMS Immunol. Med. Microbiol. 2012. 65: 467–480.
13. Grandy, G., Medina, M., Soria, R., Teran, C. G. and Araya, M., Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. 2010. 10: 253.
14. Fang, S. B., Lee, H. C., Hu, J. J., Hou, S. Y., Liu, H. L. and Fang, H. W., Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J. Trop. Pediatr. 2009. 55: 297–301.
15. Aggarwal, S., Upadhyay, A., Shah, D., Teotia, N., Agarwal, A. and Jaiswal, V., Lactobacillus GG for treatment of acute childhood diarrhoea: an open labelled, randomized controlled trial. Indian J. Med. Res. 2014. 139: 379–385.
16. Francavilla, R., Lionetti, E., Castellaneta, S., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C. et al., Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea—a double-blind study. Aliment Pharmacol. Ther. 2012. 36: 363–369.
17. Vlasova, A. N., Chattha, K. S., Kandasamy, S., Liu, Z., Esseili, M., Shao, L., Rajashekara, G. and Saif, L. J., Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs. PLoS One 2013. 8: e76962.
18. Chattha, K. S., Vlasova, A. N., Kandasamy, S., Rajashekara, G. and Saif, L. J., Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J. Immunol. 2013. 191: 2446–2456.
19. Pant, N., Marcotte, H., Brussow, H., Svensson, L. and Hammarstrom, L., Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol. 2007. 7: 86.
20. Splichalova, A., Trebichavsky, I., Rada, V., Vlkova, E., Sonnenborn, U. and Splichal, I., Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine. Clin. Exp. Immunol. 2011. 163: 242–249.
21. Kruis, W., Chrubasik, S., Boehm, S., Stange, C. and Schulze, J., A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int. J. Colorectal. Dis. 2012. 27: 467–474.
22. Hering, N. A., Richter, J. F., Fromm, A., Wieser, A., Hartmann, S., Gunzel, D., Bucker, R. et al., TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCzeta and ERK1/2 signaling in HT-29/B6 cells. Mucosal. Immunol. 2014. 7: 369–378.
23. Guttsches, A. K., Loseke, S., Zahringer, U., Sonnenborn, U., Enders, C., Gatermann, S. and Bufe, A., Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells. Innate Immun. 2012. 18: 204–216.
24. Bar, F., Von Koschitzky, H., Roblick, U., Bruch, H. P., Schulze, L., Sonnenborn, U., Bottner, M. and Wedel, T., Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol. Motil. 2009. 21: 559–566, e516–e557.
25. Altenhoefer, A., Oswald, S., Sonnenborn, U., Enders, C., Schulze, J., Hacker, J. and Oelschlaeger, T. A., The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 2004. 40: 223–229.
26. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F. and Fellermann, K., Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun. 2007. 75: 2399–2407.
27. Sturm, A., Rilling, K., Baumgart, D. C., Gargas, K., Abou-Ghazale, T., Raupach, B., Eckert, J. et al., Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005. 73: 1452–1465.
28. Kandasamy, S., Vlasova, A. N., Fischer, D., Kumar, A., Chattha, K. S., Rauf, A., Shao, L. et al., Differential effects of Escherichia coli Nissle and Lactobacillus rhamnosus strain GG on human rotavirus binding, infection, and B cell immunity. J. Immunol. 2016. 196: 1780–1789.
29. Gonzalez, A. M., Azevedo, M. S., Jung, K., Vlasova, A., Zhang, W. and Saif, L. J., Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model. Immunology 2010. 131: 242–256.
30. Deal, E. M., Lahl, K., Narvaez, C. F., Butcher, E. C. and Greenberg, H. B., Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J. Clin. Invest. 2013. 123: 2464–2474.
31. Xu, J., Yang, Y., Sun, J., Ding, Y., Su, L., Shao, C. and Jiang, B., Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea. Clin. Exp. Immunol. 2006. 144: 376–381.
32. Villena, J. and Kitazawa, H., Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol. 2014. 4: 512.
33. Belizario, J. E. and Napolitano, M., Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015. 6: 1050.
34. Robinson, C. M. and Pfeiffer, J. K., Viruses and the microbiota. Annu. Rev. Virol. 2014. 1: 55–69.
35. Goulet, O., Potential role of the intestinal microbiota in programming health and disease. Nutr. Rev. 2015. 73: 32–40.
36. Ing, R. and Stevenson, M. M., Dendritic cell and NK cell reciprocal cross talk promotes gamma interferon-dependent immunity to blood-stage Plasmodium chabaudi AS infection in mice. Infect. Immun. 2009. 77: 770–782.
37. Sarhan, D., Palma, M., Mao, Y., Adamson, L., Kiessling, R., Mellstedt, H., Osterborg, A. and Lundqvist, A., Dendritic cell regulation of NK-cell responses involves lymphotoxin-alpha, IL-12, and TGF-beta. Eur. J. Immunol. 2015. 45: 1783–1793.
38. Geldhof, A. B., Moser, M., Lespagnard, L., Thielemans, K. and De Baetselier, P., Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 1998. 91: 196–206.
39. Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B. et al., NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004. 104: 3267–3275.
40. Kalinski, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G. and Kapsenberg, M. L., IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 1997. 159: 28–35.
41. Dorman, S. E. and Holland, S. M., Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000. 11: 321–333.
42. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995. 13: 251–276.
43. Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A. and Murphy, K. M., Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993. 260: 547–549.
44. Alli, R. S. and Khar, A., Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function. FEBS Lett. 2004. 559: 71–76.
45. Gerosa, F., Gobbi, A., Zorzi, P., Burg, S., Briere, F., Carra, G. and Trinchieri, G., The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 2005. 174: 727–734.
46. Fuchsberger, M., Hochrein, H. and O'Keeffe, M., Activation of plasmacytoid dendritic cells. Immunol. Cell Biol. 2005. 83: 571–577.
47. Vlasova, A. N., Chattha, K. S., Kandasamy, S., Siegismund, C. S. and Saif, L. J., Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model. J. Immunol. 2013. 190: 4742–4753.
48. Clemente, M. G., Patton, J. T., Anders, R. A., Yolken, R. H. and Schwarz, K. B., Rotavirus infects human biliary epithelial cells and stimulates secretion of cytokines IL-6 and IL-8 via MAPK pathway. Biomed. Res. Int. 2015. 2015: 697238.
49. Narvaez, C. F., Franco, M. A., Angel, J., Morton, J. M. and Greenberg, H. B., Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin. J. Virol. 2010. 84: 4543–4555.
50. Cario, E., Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm. Bowel Dis. 2010. 16: 1583–1597.
51. Haase, R., Kirschning, C. J., Sing, A., Schrottner, P., Fukase, K., Kusumoto, S., Wagner, H., Heesemann, J. and Ruckdeschel, K., A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J. Immunol. 2003. 171: 4294–4303.
52. Fukata, M. and Abreu, M. T., TLR4 signalling in the intestine in health and disease. Biochem. Soc. Trans. 2007. 35: 1473–1478.
53. Stoll, L. L., Denning, G. M. and Weintraub, N. L., Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr. Pharm. Des. 2006. 12: 4229–4245.
54. Finamore, A., Roselli, M., Imbinto, A., Seeboth, J., Oswald, I. P. and Mengheri, E., Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants. PLoS One 2014. 9: e94891.
55. Rodriguez-Grille, J., Busch, L. K., Martinez-Costas, J. and Benavente, J., Avian reovirus-triggered apoptosis enhances both virus spread and the processing of the viral nonstructural muNS protein. Virology 2014. 462–463: 49–59.
56. Gad, M., Ravn, P., Soborg, D. A., Lund-Jensen, K., Ouwehand, A. C. and Jensen, S. S., Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria. FEMS Immunol. Med. Microbiol. 2011. 63: 93–107.
57. Ward, L. A., Rosen, B. I., Yuan, L. and Saif, L. J., Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J. Gen. Virol. 1996. 77: 1431–1441.
58. Yuan, L., Kang, S. Y., Ward, L. A., To, T. L. and Saif, L. J., Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus. J. Virol. 1998. 72: 330–338.
59. Meyer, R. C., Bohl, E. H. and Kohler, E. M., Procurement and maintenance of germ-free seine for microbiological investigations. Appl. Microbiol. 1964. 12: 295–300.
60. Yuan, L., Ward, L. A., Rosen, B. I., To, T. L. and Saif, L. J., Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 1996. 70: 3075–3083.
61. Azevedo, M. S., Yuan, L., Pouly, S., Gonzales, A. M., Jeong, K. I., Nguyen, T. V. and Saif, L. J., Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J. Virol. 2006. 80: 372–382.
62. Annamalai, T., Saif, L. J., Lu, Z. and Jung, K., Age-dependent variation in innate immune responses to porcine epidemic diarrhea virus infection in suckling versus weaned pigs. Vet. Immunol. Immunopathol. 2015. 168: 193–202.